• Login
    Browsing Food Biosciences by Author 
    •   T-Stór
    • Food Programme
    • Food Biosciences
    • Browsing Food Biosciences by Author
    •   T-Stór
    • Food Programme
    • Food Biosciences
    • Browsing Food Biosciences by Author
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of T-StórCommunitiesPublication DateAuthorsTitlesSubjectsFunderThis CollectionPublication DateAuthorsTitlesSubjectsFunderProfilesView

    My Account

    LoginRegister

    Information

    Deposit AgreementLicense

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Browsing Food Biosciences by Author "Murphy, D. M."

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    xmlui.ArtifactBrowser.ConfigurableBrowse.view

    Sort by:

    Order:

    Results:

    Now showing items 1-2 of 2

    • List view
    • Grid view
    • title
    • issue date
    • submit date
    • ascending
    • descending
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Thumbnail

        48 Altered gut microbiota in stable patients with cystic fibrosis (CF) compared to controls and its relationship with intravenous (IV) antibiotic usage and lung function

        Burke, D.G.; Fouhy, Fiona; Rea, Mary; Harrison, M.J.; STANTON, CATHERINE; O’Sullivan, Orla; Murphy, D. M.; O'Callaghan, G. P.; Eustace, J. A.; Shanahan, F.; et al. (Elsevier, 2015-06-05)
        Objective CF is associated with altered digestive function and thus nutrient availability for gut microbes in addition to altered gut microbiota, compared with healthy controls. Equally intensive antibiotic and nutritional therapy may further compound this. We present results from the largest CF gut microbiota study to date.
      • Thumbnail

        WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study – Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months

        Deane, Jennifer; Ronan, N. J.; O'Callaghan, G. P.; Fouhy, Fiona; Rea, Mary; O'Sullivan, Orla; Hill, C. J.; Shanahan, F.; Ross, R Paul; McCarthy, M.; et al. (Elsevier, 2015-06-05)
        Objectives Ivacaftor is effective in the treatment of patients with CF and the G551D gating mutation. We present faecal analysis results of the CORK cohort, a single-centre, adult (n = 20), prospective, longitudinal study of G551D clinical responders (median follow-up 12 months), examining the gut microbiota, exocrine pancreatic function and intestinal inflammation on a 3 monthly basis after commencing treatment.
        DSpace software copyright © 2002-2017  DuraSpace
        Quick Guide | Contact Us | Send Feedback
        Open Repository is a service operated by 
        Atmire NV
         

        Export search results

        The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

        By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

        To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

        After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.